Amgen Down Over 6%, on Pace for Largest Percent Decrease Since November 2024 -- Data Talk

Dow Jones
Jun 24, 2025

Amgen Inc. $(AMGN)$ is currently at $271.92, down $17.42 or 6.02%

 

--Would be lowest close since May 23, 2025, when it closed at $271.66

--On pace for largest percent decrease since Nov. 12, 2024, when it fell 7.14%

--Currently down five of the past six days

--Currently down four consecutive days; down 8% over this period

--Longest losing streak since May 6, 2025, when it fell for four straight trading days

--Worst four day stretch since the four days ending April 8, 2025, when it fell 8.32%

--Down 5.64% month-to-date; on pace for worst month since April 2025, when it fell 6.62%

--Up 4.33% year-to-date

--Down 19.4% from its all-time closing high of $337.38 on Sept. 20, 2024

--Down 14.53% from 52 weeks ago (June 24, 2024), when it closed at $318.15

--Down 19.4% from its 52-week closing high of $337.38 on Sept. 20, 2024

--Up 5.15% from its 52-week closing low of $258.59 on Jan. 6, 2025

--Traded as low as $270.32; lowest intraday level since May 23, 2025, when it hit $269.13

--Down 6.57% at today's intraday low; largest intraday percent decrease since April 10, 2025, when it fell as much as 7.36%

--Worst performer in the DJIA today

--Fourth worst performer in the S&P 500 today

--Worst performer in the Nasdaq 100 today

--Subtracted 107.08 points from the DJIA so far today

 

All data as of 2:36:44 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

June 23, 2025 14:38 ET (18:38 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10